Vitamin D, B12 and Iron: How Your DNA Affects Nutrient Absorption

India has among the world's highest rates of Vitamin D deficiency. Studies consistently show that 70–90% of urban Indians are deficient, despite living in one of the sunniest countries on earth. B12 deficiency affects over 47% of Indians — and that number is not declining despite growing awareness. Iron deficiency is the country's most prevalent nutritional problem, particularly in women of reproductive age.

The standard explanation focuses entirely on diet and lifestyle. But that explanation is incomplete. Genetics plays a significant role in who absorbs these nutrients efficiently and who does not — and understanding your genetic profile can explain why standard supplements sometimes fail to move the needle, and what to do differently.

Vitamin D: The Sunshine Paradox

The arithmetic of India's Vitamin D problem does not add up on diet and lifestyle alone. Indians get abundant sun exposure by global standards. Even accounting for increased indoor work and screen use among urban populations, the deficiency rates are far higher than sun avoidance explains.

The missing piece is genetics — specifically, how efficiently your body transports and uses the Vitamin D it does synthesise.

The GC Gene: Vitamin D's Transport Protein

After your skin synthesises Vitamin D3 from sunlight (or you absorb it from food), it does not travel freely in the blood. It binds to a carrier protein called the Vitamin D Binding Protein, encoded by the GC gene. How efficiently this protein carries Vitamin D through your bloodstream — and delivers it to tissues — depends heavily on your GC genotype.

Two variants in the GC gene, rs4588 and rs7041, together define your "GC haplotype." The three main haplotypes — Gc1f, Gc1s, and Gc2 — have meaningfully different Vitamin D binding efficiencies. Gc1f haplotypes bind Vitamin D most efficiently. Gc2 haplotypes bind it less efficiently. A person with two Gc2 alleles may have systematically lower circulating Vitamin D levels even with identical sun exposure and dietary intake compared to someone with Gc1f alleles.

VDR: The Vitamin D Receptor

Even after Vitamin D reaches your tissues, it must bind to the Vitamin D Receptor (VDR) to have a biological effect. The VDR gene has several well-studied variants — including BsmI, ApaI, TaqI, and FokI — that affect receptor activity. Some VDR genotypes require higher serum Vitamin D levels to achieve the same biological effect (bone mineralisation, immune function, gene expression) as individuals with high-activity VDR genotypes.

This means that two people can have identical blood Vitamin D levels and have substantially different biological responses to that Vitamin D — because of VDR genotype differences. This is one reason why the debate about "optimal" Vitamin D blood levels is complicated: the optimal level for biological effect is not the same for everyone.

DHCR7: Cutaneous Synthesis Efficiency

The DHCR7 gene affects the conversion of 7-dehydrocholesterol in the skin to pre-Vitamin D3 when exposed to ultraviolet B radiation. Variants in DHCR7 reduce cutaneous synthesis efficiency, meaning that the same duration of sun exposure produces less Vitamin D in the skin of some individuals than others. This gene partially explains why darker-skinned populations — who have lower UV transmission through skin — are at higher deficiency risk even at the same sun exposure levels.

Vitamin B12: The Vegetarian Problem Is Not Just Diet

India is one of the world's most vegetarian societies, so B12 deficiency is expected. B12 exists almost exclusively in animal products — meat, fish, eggs, dairy. But B12 deficiency in India also affects meat-eaters at surprising rates, and the genetic angle explains why.

FUT2: The Secretor Gene

B12 absorption requires a substance called intrinsic factor, secreted by specialised cells in the stomach lining. The FUT2 gene — the "secretor gene" — governs the secretion of certain substances by gastrointestinal epithelial cells, including factors that affect the gut environment and B12 absorption efficiency.

The FUT2 rs601338 variant determines "secretor status." Non-secretors (AA genotype, present in roughly 20% of South Asians) have an altered gut environment that reduces B12 absorption efficiency from food and standard supplements. Non-secretors show significantly lower serum B12 levels even when dietary intake appears adequate — including in meat-eaters.

If you eat animal products regularly and your B12 levels are still persistently low, FUT2 non-secretor status is one of the most common genetic explanations. The practical implication: non-secretors absorb methylcobalamin (active B12) and sublingual B12 more efficiently than standard cyanocobalamin tablets, which require gut-mediated conversion.

TCN2: Transcobalamin II

Once absorbed through the gut, B12 is transported in blood by Transcobalamin II, encoded by the TCN2 gene. Variants in TCN2 reduce transport efficiency, meaning B12 absorbed from food or supplements is less effectively delivered to cells. This can result in normal or borderline serum B12 but cellular B12 deficiency — a situation where blood tests suggest adequacy but tissues are functionally deficient.

Elevated homocysteine and methylmalonic acid (MMA) — the functional markers of B12 deficiency at the cellular level — can be elevated even when serum B12 looks acceptable in TCN2 variant carriers.

MTHFR and the B12 Connection

The MTHFR gene, best known for its role in folate metabolism, also intersects with B12 metabolism through the folate-methionine cycle. MTHFR variants reduce the efficiency of the methylation cycle that B12 participates in. Elevated homocysteine — the most common biomarker red flag in this pathway — reflects both folate and B12 adequacy. For MTHFR C677T carriers, getting the right forms of both B12 and folate is important: methylcobalamin rather than cyanocobalamin, and methylfolate rather than folic acid.

Iron: The Double-Edged Nutrient

Iron deficiency anaemia is India's most prevalent nutritional deficiency, affecting roughly 50% of women of reproductive age. But iron's genetic story runs in both directions — and misunderstanding it can lead to either under-supplementation or dangerous over-supplementation.

HFE: The Haemochromatosis Gene

The HFE gene governs hepcidin regulation and iron absorption signalling. Two key variants — C282Y and H63D — are associated with hereditary haemochromatosis, a condition in which the body absorbs excessive iron from food, accumulating it in organs over decades with serious long-term consequences (liver disease, diabetes, joint damage, cardiac problems).

C282Y is much less common in Indians than in Northern European populations. But H63D variants are present in South Asians, and compound heterozygotes — individuals who carry one copy each of C282Y and H63D — can develop clinically significant iron overload over time.

Here is the clinical paradox that makes HFE testing important: Some women diagnosed with "iron deficiency" symptoms are actually HFE compound heterozygotes who respond abnormally to standard iron supplementation. Their haemoglobin may be low due to unrelated factors, but their ferritin (stored iron) is already borderline or elevated. Supplementing iron without knowing this can accelerate organ iron accumulation. If you are persistently prescribed iron supplements and your haemoglobin does not improve as expected, asking for HFE testing is clinically warranted.

TMPRSS6: Hepcidin Regulation and Iron Absorption

Matriptase-2, encoded by the TMPRSS6 gene, regulates hepcidin — the master hormone controlling iron absorption from food. TMPRSS6 variants have been associated with both iron deficiency anaemia (when hepcidin is inappropriately elevated, blocking iron absorption) and iron overload (in other genetic contexts). Some women with persistent iron deficiency despite supplementation and dietary adequacy have TMPRSS6 variants that impair iron absorption through disrupted hepcidin signalling.

What Origins+ Covers for Nutrient Absorption

Origins+ includes genetics-based nutrient absorption analysis as part of its 26-trait wellness panel:

• Vitamin D transport efficiency (GC gene haplotypes — Gc1f, Gc1s, Gc2)
• Vitamin D receptor activity (VDR variants)
• B12 absorption status (FUT2 secretor/non-secretor genotype)
• Folate/B12 pathway efficiency (MTHFR C677T and A1298C)
• Iron metabolism indicators relevant to deficiency and absorption patterns
• Additional wellness traits covering omega-3 conversion, caffeine metabolism, antioxidant capacity, and more

All testing uses SNP microarray genotyping — a cheek swab collected at home, free shipping, results in 6–8 weeks.

How to Use These Results with a Doctor

These are not diagnoses. They are genetic tendency information that can make clinical conversations more productive. Here is how to use each category of finding:

If your GC genotype shows low Vitamin D transport efficiency: Bring your blood test (25-OH Vitamin D level) and your GC result to your GP. Discuss whether a higher-dose Vitamin D3 supplement — typically 4,000–5,000 IU daily rather than the standard 1,000–2,000 IU — is appropriate given your baseline level and genotype. Regular monitoring (every 3–6 months) is advisable when supplementing at higher doses.

If your VDR genotype shows low receptor activity: This compounds GC findings. Optimal serum Vitamin D levels for you may be at the higher end of the normal range (above 50 ng/mL) to achieve the same biological effect that someone with high-activity VDR gets at 30 ng/mL. Discuss target levels with your GP rather than accepting a generic "normal" threshold.

If your FUT2 result shows non-secretor status: Switch from standard cyanocobalamin B12 supplements to methylcobalamin, and consider sublingual forms which bypass some gut absorption steps. Discuss with your doctor whether B12 injections (bypassing gut absorption entirely) might be appropriate if oral supplementation continues to fail. Blood tests should include both serum B12 and homocysteine/MMA to capture functional deficiency.

If your MTHFR shows C677T: Switch to methylfolate (5-MTHF) rather than folic acid, and pair with methylcobalamin B12. Have homocysteine tested if you have not already — elevated homocysteine is the key functional marker that indicates the pathway is impaired. This is most clinically urgent in the context of pregnancy planning.

If your report flags HFE-relevant variants: Discuss with your GP before continuing iron supplementation. Get ferritin and transferrin saturation tested alongside haemoglobin — a complete picture of iron status, not just a haemoglobin count, is needed for HFE carriers to distinguish true deficiency from storage iron patterns.

Frequently Asked Questions

I already take Vitamin D supplements — why are my blood levels still low?

Persistent low Vitamin D levels despite supplementation are often a GC gene story. The GC gene encodes the Vitamin D binding protein that transports Vitamin D through your bloodstream. Certain GC haplotypes have lower binding efficiency, meaning Vitamin D is transported less effectively even when you are synthesising or consuming adequate amounts. VDR variants compound this by affecting how well your cells respond to the Vitamin D that does arrive. If your GC and VDR genotypes are low-efficiency, you may need higher-dose Vitamin D3 supplementation — typically discussed with a GP who has seen your blood levels and can monitor response.

Can vegetarians have normal B12 if they have a good FUT2 genotype?

FUT2 secretor status affects B12 absorption efficiency, not the source requirement. Even with an efficient FUT2 genotype, vegetarians and vegans still need dietary B12 — because B12 exists almost exclusively in animal products. What a good FUT2 genotype means is that B12 absorption from supplements or fortified foods is more efficient. For vegetarians, the practical message is: supplementation is still necessary regardless of genotype, but your genotype tells you whether standard supplement doses are sufficient or whether you need higher doses or active-form methylcobalamin.

Is it dangerous to supplement iron if you have an HFE variant?

It can be. HFE compound heterozygotes (carrying both C282Y and H63D) are associated with haemochromatosis — a condition where iron accumulates in the body over time, causing organ damage. If you have HFE variants and supplement iron without knowing your actual iron status (serum ferritin, transferrin saturation), you risk accelerating iron accumulation. If you are persistently "iron deficient" by symptoms but have HFE variants, the clinical picture should be reviewed carefully by a doctor before supplementation. Do not self-supplement iron if you know you have HFE variants — discuss with your GP first.

How does Vitamin D deficiency affect Indian women specifically?

Indian women face multiple compounding Vitamin D risk factors: darker skin pigmentation (which reduces cutaneous synthesis), cultural practices involving covered dress, indoor lifestyles in urban settings, and South Asian genetic variants affecting GC binding protein and VDR receptor efficiency. The consequences are clinically significant — Vitamin D deficiency in women of reproductive age is associated with higher rates of gestational diabetes, preeclampsia, low birth weight, and postpartum depression. In older women, it accelerates bone density loss and osteoporosis risk. Knowing your GC and VDR genotype helps determine whether standard supplementation is sufficient for you.

Can DNA results replace blood tests for checking nutrient levels?

No — they answer different questions. A blood test tells you your current nutrient status (what your levels are right now). A DNA test tells you your genetic tendency (why your levels behave the way they do over time). Both are useful and they complement each other. If your blood test shows persistently low Vitamin D despite supplementation, your DNA results can explain the underlying reason (GC or VDR variants) and inform how to address it. Use DNA results to interpret blood test patterns — not as a replacement for measuring your actual nutrient levels.